Page 3 - Clinj Am Soc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca : Update on CRYSTALIZE evidence trials - Form 6-K -December 01, 2023 at 06:29 am EST

a2725v FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

United statesUnited kingdomSharon barrColl cardiolAdrian kempSecurities exchangeEuropean medicines agency lokelmaCompany secretaryAstrazeneca pharmaceuticalsInvestor relations teamDiabetes work groupCommission file numberForeign issuerSecurities exchange actFile numberCrick avenue

Novartis iptacopan meets primary endpoint in new rare kidney disease trial

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)Ad hoc announcement pursuant to Art. 53 LRPhase III APPLAUSE-IgAN study met its pre-specified interim analysis primary endpoint, demo.

United statesShreeram aradhyeNovartis pharmaceuticalsEuropean medicines agencyExchange commissionNovartis biomedical researchChief medical officerChinook therapeuticsAbout igaTherapy designationNatl acadAlternative complement pathway with iptacopanTreat iga nephropathyKidney intEmerging roleComplement proteins

FDA Approves Defencath for Catheter-Related Infections for Those With Kidney Failure

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

United statesClinical adjudication committeeStudy assessing safetyCatheter lock solutionDialysis patientsPrevent bloodstreamClinical adjudicationSafety monitoring boardHeparin lock solutionCatheter related bloodstream infectionClinj am soc

Top Medical Alert Bracelets for Men to Stay Safe

Top Medical Alert Bracelets for Men to Stay Safe
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

United statesJohn walshLanderdahl stridsbergOther medical alert services for added safetyFall detection technologyAlert bracelet servicesAloe care healthHealth serv resTechnology optionsEvidence framework for digital health technologiesTechnology innovation in primary health care servicesResponse centersAre medical alert braceletsDigital medical alert braceletsStylish medical alertMobile help

Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial

Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesChelsea fordSharon barrBrendan mcevoyHiddo heerspinkAstrazeneca pharmaceuticalsUniversity of groningenNational kidney foundationDepartment of clinical pharmacyUniversity medical center groningenAmerican society of nephrologyAmerican societyKidney weekClinical pharmacyExecutive vice president